| Identification | Back Directory | [Name]
1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane | [CAS]
1056969-61-9 | [Synonyms]
N3-PEG7-CH2CH2Br
1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane | [Molecular Formula]
C16H32BrN3O7 | [MDL Number]
MFCD32696700 | [MOL File]
1056969-61-9.mol | [Molecular Weight]
458.35 |
| Hazard Information | Back Directory | [Uses]
Bromo-PEG7-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Bromo-PEG7-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups. | [Biological Activity]
Bromo-PEG7-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | [IC 50]
PEGs | [References]
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
|
| Company Name: |
Xinyanpomei
|
| Tel: |
15850660754 |
| Website: |
http://www.xinyanpomei.com |
|